ROBERTS 064 Pill - gray capsule/oblong
Generic Name: anagrelide
Pill with imprint ROBERTS 064 is Gray, Capsule/Oblong and has been identified as Agrylin 1 mg. It is supplied by Shire US Inc.
Agrylin is used in the treatment of Thrombocythemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROBERTS 064
Agrylin
- Generic Name
- anagrelide
- Imprint
- ROBERTS 064
- Strength
- 1 mg
- Color
- Gray
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shire US Inc.
- National Drug Code (NDC)
- 54092-0064 (Discontinued)
See also:
PegIntron
PegIntron is used to treat chronic hepatitis C in adults. Learn about side effects, interactions ...
Sylatron
Sylatron (peginterferon alfa-2b) used to prevent malignant melanoma from coming back after it has ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Advate
Advate (antihemophilic factor) is used to prevent bleeding episodes in adults and children with ...
Adzynma
Adzynma (ADAMTS13, recombinant-krhn) is a human recombinant protein that may be used to prevent or ...
Alhemo
Alhemo is used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ...
Alphanine SD
Alphanine SD is used for factor ix deficiency, hemophilia b
More about Agrylin (anagrelide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.